Literature DB >> 25260921

Somatic loss of polycystic disease genes contributes to the formation of isolated and polycystic liver cysts.

Manoe J Janssen1, Jody Salomon1, Wybrich R Cnossen1, Carsten Bergmann2, Rolph Pfundt3, Joost P H Drenth1.   

Abstract

Entities:  

Keywords:  BILIARY EPITHELIUM; DNA DAMAGE; HEPATOBILIARY DISEASE; LIVER; MOLECULAR GENETICS

Mesh：

Year:  2014        PMID： 25260921     DOI： 10.1136/gutjnl-2014-308062

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.

Authors:  Edgar S Wills; Wybrich R Cnossen; Joris A Veltman; Rob Woestenenk; Marloes Steehouwer; Jody Salomon; René H M Te Morsche; Meritxell Huch; Jayne Y Hehir-Kwa; Martijn J Banning; Rolph Pfundt; Ronald Roepman; Alexander Hoischen; Joost P H Drenth
Journal:  Eur J Hum Genet       Date:  2016-08-24       Impact factor: 4.246

2.  ALG9 Mutation Carriers Develop Kidney and Liver Cysts.

Authors:  Whitney Besse; Alex R Chang; Jonathan Z Luo; William J Triffo; Bryn S Moore; Ashima Gulati; Dustin N Hartzel; Shrikant Mane; Vicente E Torres; Stefan Somlo; Tooraj Mirshahi
Journal:  J Am Soc Nephrol       Date:  2019-08-08       Impact factor: 10.121

Review 3.  Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.

Authors:  Paula Olaizola; Pedro M Rodrigues; Francisco J Caballero-Camino; Laura Izquierdo-Sanchez; Patricia Aspichueta; Luis Bujanda; Nicholas F Larusso; Joost P H Drenth; Maria J Perugorria; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-13       Impact factor: 73.082

4.  Adult Inactivation of the Recessive Polycystic Kidney Disease Gene Causes Polycystic Liver Disease.

Authors:  Whitney Besse; Charlotte Roosendaal; Luigi Tuccillo; Sounak Ghosh Roy; Anna-Rachel Gallagher; Stefan Somlo
Journal:  Kidney360       Date:  2020-10

5.  Long-term outcome of incidental cystic liver tumors in the general population.

Authors:  S F U Blum; T Ittermann; M L Kromrey; C M Dreyer; D Seppelt; R T Hoffmann; H Völzke; J P Kühn
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

6.  Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.

Authors:  Titus F M Wijnands; Tom J G Gevers; Marten A Lantinga; René H Te Morsche; Leo J Schultze Kool; Joost P H Drenth
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.